What is quality and does it matter?

F Detterbeck - Journal of Thoracic Oncology, 2009 - jto.org
The Surveillance, Epidemiology and End Results database is designed to provide a
generalized cross-section of cancer care in the United States. It is increasingly being used to …

[引用][C] New Horizons in Staging for Non–Small-Cell Lung Cancer

D Lardinois - Journal of clinical oncology, 2006 - ascopubs.org
To determine the most appropriate therapy in patients with non–small-cell lung cancer
(NSCLC), accurate staging is mandatory. The primary goal of staging is to select patients …

The fable of Babel and building a foundation for quality

FC Detterbeck - Journal of Thoracic Oncology, 2012 - jto.org
There is no question that accurate staging, particularly of the mediastinum, plays a central
role in our current approach to lung cancer. The status of nodal involvement has a profound …

[HTML][HTML] Lung cancer staging: the value of PET depends on the clinical setting

FC Detterbeck, SF Almanzar - Journal of Thoracic Disease, 2014 - ncbi.nlm.nih.gov
Background Although positron emission tomography (PET) imaging is widely recommended
in the evaluation of patients with lung cancer, randomized controlled trials (RCTs) assessing …

[HTML][HTML] Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer

MT Vest, L Tanoue, PR Soulos, AW Kim… - Journal of Thoracic …, 2012 - Elsevier
Introduction Guidelines recommend that patients with clinical stage IIIA non-small cell lung
cancer (NSCLC) undergo histologic confirmation of pathologic lymph nodes. Studies have …

[HTML][HTML] Facility characteristics and quality of lung cancer care in an integrated health care system

JJ Ryoo, JL Malin, DL Ordin, SM Oishi, B Kim… - Journal of Thoracic …, 2014 - Elsevier
Introduction: In a national, integrated health care system, we sought to identify facility-level
attributes associated with better quality of lung cancer care. Methods: Adherence to 23 …

Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer

RC Viney, MJ Boyer, MT King, PM Kenny… - Journal of Clinical …, 2004 - ascopubs.org
Purpose Positron emission tomography (PET) is a costly new technology with potential to
improve preoperative evaluation for patients with non–small-cell lung cancer (NSCLC) …

[HTML][HTML] Improving the quality of lung cancer care in Ontario: the lung cancer disease pathway initiative

WK Evans, YC Ung, N Assouad, A Chyjek… - Journal of Thoracic …, 2013 - Elsevier
Background Before 2008, Cancer Care Ontario (CCO) undertook provincial cancer control
quality-improvement initiatives on a programmatic basis. CCO has now added Disease …

Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial

RJ Cerfolio, AS Bryant, B Ojha, M Eloubeidi - The Annals of thoracic surgery, 2005 - Elsevier
BACKGROUND: Clinical stage affects the care of patients with nonsmall cell lung cancer.
METHODS: This is a prospective trial on patients with suspected resectable nonsmall cell …

Achieving better quality of lung cancer care

RU Osarogiagbon - Lung Cancer: A Practical Approach to …, 2018 - books.google.com
Why do we need to improve the quality of lung cancer care? Lung cancer is the oncologic
public health scourge of our age, with 1.6 million annual cases and 1.4 million annual …